Home Gilead's HCV Sales May Have Peaked
 

Keywords :   


Gilead's HCV Sales May Have Peaked

2015-11-30 16:10:15| Biotech - Topix.net

A potential rate hike and a disappointing Q4 earnings season could cause a pullback in broader markets, taking GILD with it. Gilead has been a tremendous growth story ever since its HCV drug, Sovaldi/Harvoni, hit the market.

Tags: sales peaked hcv gileads

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
12.10P&O owner to attend summit despite row over minister's comments
12.10This Week in Agribusiness, Oct. 12, 2024
12.10Atlantic Tropical Weather Outlook
12.10Eastern North Pacific Tropical Weather Outlook
12.10Weekly Recap: RPM, AkzoNobel, PPG, Evonik Top This Weeks Stories
12.10Tropical Storm Leslie Graphics
12.10Tropical Storm Leslie Forecast Discussion Number 40
12.10Tropical Storm Leslie Wind Speed Probabilities Number 40
More »